Author: Zhai, Guanghua; Li, Meifen; Wang, Ying; Wu, Jian
Title: Drug-Induced Liver Disturbance During the Treatment of COVID-19 Cord-id: 660iqv6a Document date: 2021_8_18
ID: 660iqv6a
Snippet: An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have different degrees of liver disturbance. However, the relationship between the drugs used for COVID-19 treatment and liver disturbance remains controversial. It is essential to evaluate the potential liv
Document: An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have different degrees of liver disturbance. However, the relationship between the drugs used for COVID-19 treatment and liver disturbance remains controversial. It is essential to evaluate the potential liver damage caused by various drugs in order to help guide clinical practice. This review analyzed the effect of drugs on hepatic function during the treatment of COVID-19.
Search related documents:
Co phrase search for related documents- abdominal discomfort and liver disease: 1
- abdominal discomfort and liver function: 1
- abdominal discomfort and liver injury: 1
- abdominal discomfort and liver treatment: 1
Co phrase search for related documents, hyperlinks ordered by date